NIDDK Funding Opportunity

P01 Program Project Grant, P20 Center Exploratory Grant, P30 Center Core Grant, P50 Specialized Center Grant, U54 Specialized Center Cooperative Agreement, DP1 NIH Director’s Pioneer Award, DP2 NIH Director’s New Innovator Award, DP2 NIH Director’s New Innovator Awards, DP3 Type 1 Diabetes Targeted Research Award, DP5 Early Independence Award, K01 Research Scientist Development Award, K05 Research Scientist Award, K08 Clinical Investigator Award, K12 Physician Scientist Award, K23 Mentored Patient-Oriented Research Career Development Award, K24 Midcareer Investigator Award in Patient-Oriented Research, K25 Mentored Quantitative Research Career Development Award, K99/R00 Pathway to Independence Award, R01 Research Project Grant, R03 Small Research Grant Program, R15 Academic Research Enhancement Award (AREA), R21 Exploratory/Developmental Grant, R24 Resource-Related Research Project, R41/R42 Small Business Technology Transfer Grant (STTR), R43/R44 Small Business Innovation Research Grants (SBIR), U01 Research Project Cooperative Agreement, U24 Resource-Related Research Projects - Cooperative Agreement See the Full Announcement for the list of all related Funding Mechanisms.

Administrative Supplements to NIH Awards for Validation Studies of Analytical Methods for Natural Products (Admin Supp)

The publication of reliable analytical methods for quantitative determination of chemical constituents of natural products and dietary supplements can make critical contributions to the rigor and reproducibility of biomedical research. In order to support formal validation studies and publication of relevant quantitative analytical chemistry methods, Administrative Supplements to certain active awards administered by the participating ICs are available through this FOA. The methods proposed for validation must be used to identify and quantify chemical constituents (active or marker chemical compounds, adulterants, contaminants, or metabolites thereof) in experimental reagents, raw materials, and/or clinical specimens (for example urine or plasma samples). Methods must have been developed or utilized in fulfillment of the active parent grants specific aims. Candidate constituents for quantitative method validation studies may include (but are not limited to):phytochemicals; nutrients; and potentially deleterious substances such as pesticides and mycotoxins.

Full AnnouncementPA-16-048
Notice(s) for this Opportunity

January 6, 2016 - Notice of Participation of the National Institute of Environmental Health Sciences (NIEHS) in PA-16-048. See Notice NOT-ES-16-004.

NOT-OD-16-004 - NIH & AHRQ Announce Upcoming Changes to Policies, Instructions and Forms for 2016 Grant Applications (November 18, 2015)

Open Date12/15/2015
Letter of Intent Due Date
Not Applicable
Application Due Date

​January 15, 2016; April 15, 2016; October 15, 2016; January 15, 2017; April 15, 2017, by 5:00 PM local time of applicant organization.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Program ContactPadma Maruvada, Ph.D.
Opportunity Resources
Small Business Opportunities

Click outside of the light box to close the box.